Sweden Oral Solid Dosage Contract Manufacturing Market Size & Outlook
The oral solid dosage contract manufacturing market in Sweden is expected to reach a projected revenue of US$ 486.9 million by 2030. A compound annual growth rate of 5.1% is expected of Sweden oral solid dosage contract manufacturing market from 2025 to 2030.
HC Outsourcing
CMO/CDMO
Oral Solid Dosage Contract Manufacturing Market Outlook
Sweden oral solid dosage contract manufacturing market highlights
The Sweden oral solid dosage contract manufacturing market generated a revenue of USD 361.6 million in 2024 and is expected to reach USD 486.9 million by 2030.
The Sweden market is expected to grow at a CAGR of 5.1% from 2025 to 2030.
In terms of segment, tablets was the largest revenue generating product in 2024.
Capsules is the most lucrative product segment registering the fastest growth during the forecast period.
Oral solid dosage contract manufacturing market data book summary
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Europe, Germany oral solid dosage contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
Germany is the fastest growing regional market in Europe and is projected to reach USD 2,689.8 million by 2030.
Sweden holds a strong position in drug development space. The current scenario for pharmaceutical CMOs & CROs in Sweden is that the country has a well-established and growing pharmaceutical industry, which is known for its innovation and research.
The country's pharmaceutical industry is very strategic, focusing on world-class innovation and excellent R&D. In Sweden, oral solid dosage contract manufacturing plays a crucial role in developing new pharmaceuticals such as oral solid dosage drugs.
Sweden Oral Solid Dosage Contract Manufacturing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Oral Solid Dosage Contract Manufacturing Market Outlook will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 31.86% in 2024.
Horizon Databook has segmented the Sweden oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.
Sweden holds a strong position in drug development space. The current scenario for pharmaceutical CMOs & CROs in Sweden is that the country has a well-established and growing pharmaceutical industry, which is known for its innovation and research.
The country's pharmaceutical industry is very strategic, focusing on world-class innovation and excellent R&D. In Sweden, oral solid dosage contract manufacturing plays a crucial role in developing new pharmaceuticals such as oral solid dosage drugs.
Sweden Oral Solid Dosage Contract Manufacturing Market Product Outlook (Revenue, USD Million , 2018-2030)
Tablets
Capsules
Powders
Granules
Others
Sweden Oral Solid Dosage Contract Manufacturing Market Mechanism Outlook (Revenue, USD Million , 2018-2030)
Immediate Release
Delayed Release
Controlled Release
Sweden Oral Solid Dosage Contract Manufacturing Market End User Outlook (Revenue, USD Million , 2018-2030)
Large Size Companies
Medium & Small Size Companies
Others
Reasons to subscribe to Oral Solid Dosage Contract Manufacturing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Oral Solid Dosage Contract Manufacturing Market Outlook databook
Our clientele includes a mix of Oral Solid Dosage Contract Manufacturing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden Oral Solid Dosage Contract Manufacturing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Sweden Oral Solid Dosage Contract Manufacturing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sweden Oral Solid Dosage Contract Manufacturing Market, 2018-2030 (US$M)